Litigation Details for BAUSCH HEALTH IRELAND LIMITED v. MSN LABORATORIES PRIVATE LTD. (D.N.J. 2021)
✉ Email this page to a colleague
BAUSCH HEALTH IRELAND LIMITED v. MSN LABORATORIES PRIVATE LTD. (D.N.J. 2021)
| Docket | ⤷ Sign Up | Date Filed | 2021-04-22 |
| Court | District Court, D. New Jersey | Date Terminated | |
| Cause | 35:271 Patent Infringement | Assigned To | Stanley R. Chesler |
| Jury Demand | None | Referred To | Jessica S. Allen |
| Parties | BAUSCH HEALTH IRELAND LIMITED | ||
| Patents | 10,011,637; 7,041,786; 7,799,897; 8,637,451; 9,610,321; 9,616,097; 9,919,024; 9,925,231 | ||
| Attorneys | J. BRUGH LOWER | ||
| Firms | Barnes & Thornburg LLP | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in BAUSCH HEALTH IRELAND LIMITED v. MSN LABORATORIES PRIVATE LTD.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for BAUSCH HEALTH IRELAND LIMITED v. MSN LABORATORIES PRIVATE LTD. (D.N.J. 2021)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2021-04-22 | 1 | Complaint | ’024 patent”), 9,925,231 (“the ’231 patent”) and 10,011,637 (“the ’637 patent”) arising under the United… patent, the ’451 patent, the ’321 patent, the ’097 patent, the ’024 patent, the ’231 patent and the…’786 patent, the ’897 patent, the ’451 patent, the ’321 patent, the ’097 patent, the ’024 patent, the…’786 patent, the ’897 patent, the ’451 patent, the ’321 patent, the ’097 patent, the ’024 patent, the… United States Patent Nos. 7,041,786 (“the ’786 patent”), 7,799,897 (“the ’897 patent”), 8,637,451 (“ | External link to document |
| 2023-04-20 | 136 | Opinion | this product. Bausch owns U.S. Patent No. 10,011,637 (“the ’637 patent.”). The parties seek claim construction…intrinsic to the patent (the patent claims and specifications, along with the patent’s prosecution history… It is a bedrock principle of patent law that the claims of a patent define the invention to… arises from Hatch-Waxman litigation regarding patents related to the branded drug Trulance®, with active…construction of four terms in this patent. ANALYSIS I. | External link to document |
| 2021-08-10 | 25 | Order | to [United States Patent Nos. 7,799,897 ("'897 patent") and 8,637,451 ("'451 patent")] under 21 U.S.C.… 22 April 2021 2:21-cv-10057 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
